Skip to main content

Dermatological Non-Disease

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Syneos Health
Syneos HealthNC - Morrisville
1 program
Princess Filler LidocaineN/A1 trial
Active Trials
NCT03990883Completed295Est. Feb 2022
Croma-Pharma
Croma-PharmaAustria - Leobendorf
1 program
Princess Filler LidocaineN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Syneos HealthPrincess Filler Lidocaine

Clinical Trials (1)

Total enrollment: 295 patients across 1 trials

NCT03990883Syneos HealthPrincess Filler Lidocaine

Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)

Start: Jun 2019Est. completion: Feb 2022295 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.